CINA-CSpine vs CINA-iPE
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (CINA-CSpine) is designed for the rapid detection of acute cervical spine fractures on neck CT scans, while Tool B (CINA-iPE) focuses on detecting incidental pulmonary embolisms across various CT scan types. While both are FDA-cleared AI triage tools from the same vendor, they address distinct medical conditions and therefore serve different diagnostic needs within a radiology workflow.
Choose CINA-CSpine if…
Choose CINA-CSpine if your primary concern is the rapid and accurate detection of acute cervical spine fractures on non-enhanced neck CT scans, particularly in emergency or trauma settings. This tool is ideal for enhancing diagnostic confidence and expediting patient care when a compromised spine is suspected.
View CINA-CSpine →Choose CINA-iPE if…
Choose CINA-iPE if your goal is to proactively identify unsuspected pulmonary embolisms on CT scans performed for a wide range of other conditions. This solution is crucial for preventing missed diagnoses and enabling early intervention for incidental findings that could significantly impact patient outcomes.
View CINA-iPE →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA-CSpine | CINA-iPE |
|---|---|---|
| Pricing | Subscription | Subscription |
| Deployment | Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA-CSpine | CINA-iPE |
|---|---|---|
| Name | CINA-CSpine | CINA-iPE |
| Primary Detection Focus | Detects acute cervical spine fractures on non-enhanced neck CT scans | Detects unsuspected pulmonary embolisms on CT scans performed for other health conditions |
| Target CT Scan Types | Non-enhanced neck CT scans | Various CT scan types (chest, abdomen-pelvis, thoraco-abdominal, whole-body) |
| Specialties | Emergency Medicine, Neurosurgery, Radiology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CINA-CSpine and CINA-iPE.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
CINA-CSpine rapidly detects acute cervical spine fractures on non-enhanced neck CTs, aiding emergency medicine, neurosurgery, and radiology by flagging potential fractures for timely intervention and reducing diagnostic delays. CINA-iPE identifies incidental pulmonary embolisms on various CT scan types, benefiting emergency medicine, pulmonology, and radiology by enabling early treatment and preventing missed diagnoses. Both tools aim to improve diagnostic accuracy and patient outcomes by triaging critical findings.
Both CINA-CSpine and CINA-iPE integrate seamlessly into standard radiology reading environments like PACS and RIS, supporting global healthcare data standards such as DICOM, HL7, and FHIR. This allows for automated flagging and notification of critical findings directly within the existing workflow, without requiring new viewers or changes to clinical workflows. The adherence to FHIR suggests potential for broader data exchange with EHR systems.
CINA-CSpine achieved an overall sensitivity of 90.3% and specificity of 91.9% for acute cervical spine fracture detection, validated on over 300 non-contrast CT scans from multiple sources and vendors. CINA-iPE demonstrated a sensitivity of 87.8% and specificity of 92.0% for incidental pulmonary embolism detection, validated on 381 CT scans from various manufacturers. Both tools were validated in multi-center, multi-national, and multi-vendor studies.
Avicenna.AI's AVI platform, which hosts both tools, is designed for 'zero disruption to clinical workflows' and 'no extra training required, no changes to workflow, no new viewers and no additional clicks.' This suggests a minimal learning curve for physicians, as AI insights appear automatically within their usual diagnostic tools. The rapid processing times (e.g., 10-60 seconds for CINA-iPE) and automated notifications indicate a quick time-to-value by accelerating diagnostic pathways.
Avicenna.AI's AVI platform is designed for scalability, enabling deployment across single sites to complex hospital networks and teleradiology providers. The company has experience rolling out its AI solutions to over 140 hospitals in 14 countries, indicating robust support for diverse deployment scenarios. Centralized configuration and orchestration capabilities streamline management for IT departments.
Avicenna.AI's AVI platform incorporates full audit trails, which are secure, computer-generated, and time-stamped electronic records. These audit trails log and track modifications and interactions, providing a detailed view of data and protocol changes. This facilitates accountability, traceability, and performance analysis, allowing physicians to track AI-assisted decisions and their clinical impact.